Mercator MedSystems
San Leandro, US · Delaware corporation · 2 known investors
Mercator MedSystems develops the Bullfrog microinfusion device for targeted anti-inflammatory drug delivery to treat deep vein thrombosis and peripheral arterial disease. The company conducts clinical trials to improve patient outcomes in vascular conditions through perivenous and local drug injection technologies.
BiotechHealthtechMedical Devices
Founders & leadership
TR
Trent ReutimanExecutive Officer, Director
SB
Stephen BakerExecutive Officer
KS
Kirk SewardExecutive Officer
CC
Charles CrockerDirector
DW
Doug WallDirector
NS
Ned ScheetzDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$14.3MraisedJun 2019 · 25 investors · Other Health CareRule 506(b)
▶$14.3MraisedJun 2019 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Trent ReutimanExecutive Officer, Director
- Stephen BakerExecutive Officer
- Kirk SewardExecutive Officer
- Charles CrockerDirector
- Ned ScheetzDirector
- Doug WallDirector
- Offering amount
- $15M
- Amount sold
- $14.3M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2011 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2009 | $218.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $194.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.